Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Net Income (2017 - 2025)

Catheter Precision (VTAK) has disclosed Net Income for 9 consecutive years, with -$4.5 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 79.57% to -$4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16.2 million through Dec 2025, down 19.66% year-over-year, with the annual reading at -$19.5 million for FY2025, 44.46% down from the prior year.
  • Net Income for Q4 2025 was -$4.5 million at Catheter Precision, down from -$2.2 million in the prior quarter.
  • The five-year high for Net Income was $3.1 million in Q3 2021, with the low at -$66.4 million in Q1 2023.
  • Average Net Income over 5 years is -$6.8 million, with a median of -$4.1 million recorded in 2024.
  • The sharpest move saw Net Income skyrocketed 1266.67% in 2021, then crashed 1430.64% in 2022.
  • Over 5 years, Net Income stood at $3.1 million in 2021, then tumbled by 364.9% to -$8.2 million in 2022, then skyrocketed by 91.8% to -$669000.0 in 2023, then tumbled by 271.75% to -$2.5 million in 2024, then crashed by 79.57% to -$4.5 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$4.5 million, -$2.2 million, and -$5.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.